Clenbuterol and Metformin Ameliorate Cachexia Parameters, but Only Clenbuterol Reduces Tumor Growth Via Lipid Peroxidation in Walker 256 Tumor-bearing Rats

Overview

Journal Braz J Med Biol Res

Date 2025 Feb 5

PMID 39907424

Authors

L D V Henschel

M E R de Lima

F C Fagundes

T Horlem

M F Zazula

K Naliwaiko

L C Fernandes

Affiliations

Soon will be listed here.

Abstract

Cancer is the second leading cause of death worldwide. Cancer cachexia is a multifactorial catabolic syndrome responsible for almost one third of cancer-related deaths. Drug repurposing has been used in oncological research and drugs like clenbuterol and metformin seem to be reasonable candidates in the context of cancer cachexia, because the former is a β2-agonist that stimulates muscle gain and the latter has anti-inflammatory properties. The aim of this study was to assess the effects of a short-term treatment with metformin and clenbuterol, isolated or combined, on tumor growth and cancer cachexia parameters in Walker 256 tumor-bearing rats, a model of cancer cachexia. To this end, Wistar rats were separated into 8 groups and 4 of them were injected with Walker 256 tumor cells (W groups). Control (C) and W groups received the following treatments: metformin (M), clenbuterol (Cb), or metformin combined with clenbuterol (MCb). Body and tumor weight, metabolic parameters, and oxidative damage in the tumor were assessed. Compared to the C group, the W group showed body weight loss, hypoglycemia, hyperlactatemia, and hypertriacylglycerolemia. None of the treatments could reverse body weight loss, although they reversed the alterations of the assessed plasma metabolic parameters. Surprisingly, only clenbuterol alone reduced tumor weight. Hydrogen peroxide production and lipid peroxidation in tumor tissue was increased in this group. In conclusion, metformin and clenbuterol ameliorated metabolic cachexia parameters in Walker tumor-bearing rats, but only clenbuterol reduced the tumor weight, probably, through a lipid peroxidation-dependent cell death.

References

Kline W, Panaro F, Yang H, Bodine S . Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol (1985). 2006; 102(2):740-7. DOI: 10.1152/japplphysiol.00873.2006. View

Jessen S, Solheim S, Jacobson G, Eibye K, Bangsbo J, Nordsborg N . Beta -adrenergic agonist clenbuterol increases energy expenditure and fat oxidation, and induces mTOR phosphorylation in skeletal muscle of young healthy men. Drug Test Anal. 2019; 12(5):610-618. DOI: 10.1002/dta.2755. View

Pernicova I, Korbonits M . Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014; 10(3):143-56. DOI: 10.1038/nrendo.2013.256. View

Li L, Wazir J, Huang Z, Wang Y, Wang H . A comprehensive review of animal models for cancer cachexia: Implications for translational research. Genes Dis. 2024; 11(6):101080. PMC: 11364047. DOI: 10.1016/j.gendis.2023.101080. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Pizato N, Bonatto S, Piconcelli M, de Souza L, Sassaki G, Naliwaiko K . Fish oil alters T-lymphocyte proliferation and macrophage responses in Walker 256 tumor-bearing rats. Nutrition. 2006; 22(4):425-32. DOI: 10.1016/j.nut.2005.11.001. View

Costelli P, Llovera M, Carbo N, Lopez-Soriano F, Agell N, Tessitore L . Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest. 1995; 95(5):2367-72. PMC: 295859. DOI: 10.1172/JCI117929. View

Pinto Jr J, Folador A, Bonato S, Aikawa J, Yamazaki R, Pizato N . Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats. J Nutr Biochem. 2004; 15(6):358-65. DOI: 10.1016/j.jnutbio.2004.02.002. View

Sedlak J, Lindsay R . Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968; 25(1):192-205. DOI: 10.1016/0003-2697(68)90092-4. View

10.

Pizato N, Bonatto S, Yamazaki R, Aikawa J, Nogata C, Mund R . Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Nutr Cancer. 2006; 53(2):194-201. DOI: 10.1207/s15327914nc5302_8. View

11.

Vancura A, Bu P, Bhagwat M, Zeng J, Vancurova I . Metformin as an Anticancer Agent. Trends Pharmacol Sci. 2018; 39(10):867-878. PMC: 6153060. DOI: 10.1016/j.tips.2018.07.006. View

12.

Martin-Montalvo A, Mercken E, Mitchell S, Palacios H, Mote P, Scheibye-Knudsen M . Metformin improves healthspan and lifespan in mice. Nat Commun. 2013; 4:2192. PMC: 3736576. DOI: 10.1038/ncomms3192. View

13.

Piffar P, Fernandez R, Tchaikovski O, Hirabara S, Folador A, Pinto G . Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. Cancer Lett. 2003; 201(2):139-48. DOI: 10.1016/s0304-3835(03)00472-5. View

14.

Brown J, Chan D, Shank J, Griffith K, Fan H, Szulawski R . Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. JCI Insight. 2020; 5(11). PMC: 7308054. DOI: 10.1172/jci.insight.133247. View

15.

Collins S . β-Adrenoceptor Signaling Networks in Adipocytes for Recruiting Stored Fat and Energy Expenditure. Front Endocrinol (Lausanne). 2012; 2:102. PMC: 3355892. DOI: 10.3389/fendo.2011.00102. View

16.

Chance W, Cao L, Zhang F, Fischer J . Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition. Am J Surg. 1991; 161(1):51-6. DOI: 10.1016/0002-9610(91)90360-p. View

17.

Armstrong R, Phelps R . Muscle fiber type composition of the rat hindlimb. Am J Anat. 1984; 171(3):259-72. DOI: 10.1002/aja.1001710303. View

18.

Hare J, Beigi F, Tziomalos K . Nitric oxide and cardiobiology-methods for intact hearts and isolated myocytes. Methods Enzymol. 2008; 441:369-92. DOI: 10.1016/S0076-6879(08)01221-4. View

19.

Yerevanian A, Soukas A . Metformin: Mechanisms in Human Obesity and Weight Loss. Curr Obes Rep. 2019; 8(2):156-164. PMC: 6520185. DOI: 10.1007/s13679-019-00335-3. View

20.

Schmidt S, Rohm M, Herzig S, Diaz M . Cancer Cachexia: More Than Skeletal Muscle Wasting. Trends Cancer. 2018; 4(12):849-860. DOI: 10.1016/j.trecan.2018.10.001. View